Actively Recruiting

Age: 40Years - 95Years
MALE
NCT07203482

Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation

Led by NYU Langone Health · Updated on 2025-10-02

300

Participants Needed

2

Research Sites

1389 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Many reports of clinical outcomes following treatment of localized prostate cancer suffer from lack of prospective long-term data using objective and validated outcome instruments. The purpose of this research database is to prospectively collect data to assess treatment related complications, oncologic outcomes and urinary/sexual function, and identify predictors of complications, oncological control and functional outcomes after Hhigh-intensity focused ultrasound (HIFU) ablation of prostate cancer with the intent to guide further research and improve patient care. We will include subjects who will have a HIFU procedure performed from all Sub-Investigators included in the study.

CONDITIONS

Official Title

Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation

Who Can Participate

Age: 40Years - 95Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male, aged 40 to 95 years
  • Evidence of focal prostate cancer confined to the prostate confirmed by MRI and biopsy
  • Clinically localized prostate cancer without evidence or concern of metastatic spread
  • Selected focal HIFU prostate ablation as treatment option
  • Early low grade cancer (Gleason 6 or 7) confined to the prostate
  • Willing and able to provide consent
Not Eligible

You will not qualify if you...

  • Not diagnosed with prostate cancer
  • Diagnosed with clinically localized prostate cancer but chose other treatments
  • Unwilling or unable to provide consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

NYU Langone Health - Cobble Hill

Brooklyn, New York, United States, 11201

Actively Recruiting

2

NYU Langone Health - Tisch Hospital

New York, New York, United States, 10016

Actively Recruiting

Loading map...

Research Team

M

Majlinda Tafa, MD

CONTACT

J

James Wysock, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here